help button home button Am J Pathol ASIP 2008 Summer Academy, Molecular Methcanisms of Human Disease: Injury, Inflammation, and Tissue Repair
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, Q. C.
Right arrow Articles by Marzella, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, Q. C.
Right arrow Articles by Marzella, L.

American Journal of Pathology, Vol 122, 553-561, Copyright © 1986 by American Society for Investigative Pathology

REGULAR ARTICLES

Modification of lysosomal proteolysis in mouse liver with taxol

QC Yu and L Marzella

Perturbation of lysosomal degradation pathways by drugs such as chloroquine and vinblastine has given us important insights into the means for segregation and degradation of cytoplasm by the lysosomes. Vinblastine (VBL) is a microtubule depolymerizer which increases the number of autophagosomes and also impairs the maturation of the autophagosomes into secondary lysosomes. The authors have tested the effects of the microtubule stabilizer taxol on the proteolytic activity of the lysosomal system in VBL-treated mice. Liver proteins of CD-1 mice were radioisotopically labeled. Taxol and/or vinblastine were subsequently administered. Proteolysis in liver homogenates was determined during in vitro incubation by measuring the release of trichloroacetic acid-soluble radioactivity over time. Taxol enhanced proteolysis in homogenates from VBL-treated mice. The site of the enhanced proteolysis was lysosomal, because it was demonstrated in a crude lysosomal fraction, it manifested an acid pH optimum, and it could be suppressed with cycloheximide. Morphometric analysis indicated that taxol caused a shift in hepatocyte lysosomes of VBL-treated mice toward the later stages of the degradation cycle, coupled with a decrease in the number of small dense body profiles. The results indicate that taxol enhances the maturation of the autophagosomes into proteolytically active secondary lysosomes. It is concluded that the microtubule stabilizer taxol enhances fusion between VBL-induced autophagosomes and lysosomes (small dense bodies) and does not affect the segregation of cytoplasm into autophagosomes.


This article has been cited by other articles:


Home page
 CarcinogenesisHome page
G. Rez, S. Toth, and Z. Palfia
Cellular autophagic capacity is highly increased in azaserine-induced premalignant atypical acinar nodule cells
Carcinogenesis, October 1, 1999; 20(10): 1893 - 1898.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by the American Society for Investigative Pathology.